Get the Stockscreener App
1.03
2.83%
-0.03
After Hours:
1.00
-0.03
-2.91%
Cytosorbents Corp Stock (CTSO) Forecast
The Cytosorbents Corp (CTSO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.5536, representing a +50.83% increase from the current price of $1.03. The highest analyst price target is $2.8871, and the lowest is $0.22.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTSO Price Target
Average 3.7331
(+262.44% Upside)
Is Cytosorbents Corp (CTSO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.73 | Neutral |
| STOCH(9,6) | 12.19 | Buy |
| STOCHRSI(14) | 9.7132 | Buy |
| MACD(12,26) | 0.0136 | Sell |
| ADX(14) | 30.81 | Buy |
| William %R | -92.06 | Buy |
| CCI(14) | -69.65 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.114
Sell
|
1.092
Sell
|
| MA20 |
1.1014
Sell
|
1.0904
Sell
|
| MA50 |
1.0218
Buy
|
1.0506
Sell
|
| MA100 |
0.9995
Buy
|
1.0316
Sell
|
| MA200 |
1.014
Buy
|
1.041
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, CTSO could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CTSO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.73 indicates that CTSO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.19 indicates that CTSO is oversold. This indicates that CTSO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.7132 indicates that CTSO is oversold. This suggests that CTSO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.81 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -69.65 indicates that CTSO is still oversold but not to an extreme extent.
Long-term CTSO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cytosorbents Corp financial reports and earnings history, Cytosorbents Corp (CTSO) stock could reach $4.7052 by 2030, $2.2999 by 2040 and $11.01 by 2050. See the projected annual prices until 2050 of the Cytosorbents Corp stock below:
- Cytosorbents Corp (CTSO) is expected to reach an average price of $1.1497 in 2035, with a high prediction of $1.0883 and a low estimate of $1.0954. This indicates an $11.62% rise from the last recorded price of $1.03.
- Cytosorbents Corp (CTSO) stock is projected to chart a bullish course in 2040, with an average price target of $2.8699, representing an $178.63% surge from its current level. The forecast ranges from a conservative $2.3007 to a sky-high $2.2999.
- Our analysts predict Cytosorbents Corp (CTSO) to jump 646.59% by 2045, soaring from $7.7814 to an average price of $7.6899, potentially reaching $7.8571. While $7.7814 is the low estimate, the potential upside is significant.
- Cytosorbents Corp (CTSO) stock is expected to climb by 2050, reaching an average of $11.08, a $975.56% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.01 and $10.91, respectively, highlighting the market's uncertainty.
Cytosorbents Corp Stock (CTSO) Year by Year Forecast
Cytosorbents Corp Stock (CTSO) Price Forecast for 2025
Cytosorbents Corp Stock (CTSO) is expected to reach an average price of $3.6367 in 2025, with a high prediction of $7.2462 and a low estimate of $0.0272. This indicates an +253.08% rise from the last recorded price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $2.7971 | $0.22 | $2.8871 | +171.57% |
| May, 2025 | $3.2243 | $1.2907 | $4.6275 | +213.04% |
| June, 2025 | $5.6615 | $3.4479 | $6.5615 | +449.66% |
| July, 2025 | $4.3555 | $3.8219 | $6.5551 | +322.86% |
| August, 2025 | $5.6126 | $4.1823 | $5.9519 | +444.92% |
| September, 2025 | $5.0898 | $4.803 | $7.2462 | +394.16% |
| October, 2025 | $3.0838 | $2.8838 | $5.2585 | +199.39% |
| November, 2025 | $3.6659 | $2.7706 | $4.5774 | +255.92% |
| December, 2025 | $3.4249 | $3.3349 | $5.1313 | +232.52% |
Cytosorbents Corp Stock (CTSO) Price Forecast for 2026
The predicted value for Cytosorbents Corp (CTSO) in 2026 is set at an average of $5.5263. Estimates vary from a peak of $7.7108 to a trough of $3.3417, indicating an +436.53% surge from the present price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.2021 | $3.3417 | $5.1217 | +307.97% |
| February, 2026 | $4.3893 | $3.7457 | $5.1893 | +326.14% |
| March, 2026 | $4.5564 | $3.8528 | $5.4173 | +342.37% |
| April, 2026 | $7.1104 | $4.6032 | $7.7108 | +590.33% |
| May, 2026 | $5.1676 | $3.914 | $7.2172 | +401.70% |
| June, 2026 | $5.0947 | $4.2011 | $5.3447 | +394.63% |
| July, 2026 | $4.5787 | $3.9387 | $5.6819 | +344.53% |
| August, 2026 | $4.6859 | $4.2291 | $5.5959 | +354.94% |
| September, 2026 | $4.4198 | $3.763 | $5.1898 | +329.11% |
| October, 2026 | $4.267 | $3.487 | $4.827 | +314.27% |
| November, 2026 | $6.1342 | $3.7755 | $6.2842 | +495.55% |
| December, 2026 | $4.7781 | $4.5581 | $6.381 | +363.90% |
Cytosorbents Corp Stock (CTSO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cytosorbents Corp (CTSO) is $2.4486, with a high forecast of $4.8749 and a low forecast of $0.0223. This indicates an +137.73% increase from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.5353 | $2.5053 | $4.8749 | +146.15% |
| February, 2027 | $2.0225 | $2.0125 | $3.4057 | +96.36% |
| March, 2027 | $1.4165 | $1.1465 | $2.2497 | +37.52% |
| April, 2027 | $0.1536 | $0.1136 | $1.4832 | -85.08% |
| May, 2027 | $0.6408 | $0.1704 | $0.9408 | -37.79% |
| June, 2027 | $0.9648 | $0.5512 | $1.2348 | -6.33% |
| July, 2027 | $0.3419 | $0.0251 | $1.0616 | -66.80% |
| August, 2027 | $0.2109 | $0.0223 | $0.5287 | -79.53% |
| September, 2027 | $0.6469 | $0.6587 | $0.5369 | -37.19% |
| October, 2027 | $0.7498 | $0.7798 | $0.6533 | -27.21% |
| November, 2027 | $0.1026 | $0.5676 | $0.3744 | -90.04% |
| December, 2027 | $0.5686 | $0.429 | $0.2986 | -44.79% |
Cytosorbents Corp Stock (CTSO) Price Forecast for 2028
In 2028, Cytosorbents Corp (CTSO) is projected to reach an average price of $1.3316, with a high projection of $2.6152 and a low estimate of $0.048. This indicates an +29.28% rise from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5614 | $0.5982 | $0.5014 | -45.49% |
| February, 2028 | $0.9843 | $0.6479 | $0.8243 | -4.44% |
| March, 2028 | $0.3903 | $0.5603 | $0.5807 | -62.11% |
| April, 2028 | $0.6831 | $0.6935 | $0.6731 | -33.68% |
| May, 2028 | $0.7092 | $0.7995 | $0.8336 | -31.15% |
| June, 2028 | $0.058 | $0.048 | $0.4224 | -94.37% |
| July, 2028 | $1.5252 | $0.0848 | $2.6152 | +48.08% |
| August, 2028 | $1.6891 | $1.1456 | $2.3091 | +63.99% |
| September, 2028 | $1.3663 | $1.2059 | $1.7412 | +32.65% |
| October, 2028 | $1.0235 | $0.5567 | $1.5928 | -0.63% |
| November, 2028 | $1.4075 | $0.9303 | $1.937 | +36.65% |
| December, 2028 | $1.9846 | $1.3442 | $2.0577 | +92.68% |
Cytosorbents Corp Stock (CTSO) Price Forecast for 2029
The 2029 price forecast for Cytosorbents Corp Stock (CTSO) is $1.8144 on average, with a high prediction of $3.6276 and a low estimate of $0.00125. This represents an +76.16% increase from the previous price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.0486 | $1.5976 | $2.7182 | +98.89% |
| February, 2029 | $1.0358 | $1.0083 | $2.1954 | +0.56% |
| March, 2029 | $0.5929 | $0.5729 | $1.2611 | -42.43% |
| April, 2029 | $0.3901 | $0.2101 | $0.7797 | -62.13% |
| May, 2029 | $0.0341 | $0.0359 | $0.6737 | -96.69% |
| June, 2029 | $0.00125 | $0.00125 | $0.2527 | -99.88% |
| July, 2029 | $0.00842 | $0.00804 | $1.0316 | -99.18% |
| August, 2029 | $0.00761 | $0.0676 | $0.048 | -99.26% |
| September, 2029 | $0.0296 | $0.0172 | $0.0796 | -97.13% |
| October, 2029 | $0.0234 | $0.00365 | $0.1667 | -97.73% |
| November, 2029 | $0.0027 | $0.0127 | $0.1871 | -99.74% |
| December, 2029 | $4.8286 | $0.00749 | $3.6276 | +368.80% |
Cytosorbents Corp Stock (CTSO) Price Forecast for 2030
Cytosorbents Corp Stock (CTSO) is expected to reach an average price of $4.7533 in 2030, with a high forecast of $6.1195 and a low forecast of $3.3871. This signifies an +361.49% surge from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1107 | $4.7719 | $4.7052 | +396.18% |
| February, 2030 | $3.9663 | $4.5363 | $4.3471 | +285.08% |
| March, 2030 | $4.112 | $3.9592 | $3.662 | +299.22% |
| April, 2030 | $6.3176 | $5.3784 | $6.0276 | +513.36% |
| May, 2030 | $5.5197 | $5.2969 | $5.974 | +435.89% |
| June, 2030 | $5.7454 | $5.9154 | $5.8139 | +457.80% |
| July, 2030 | $5.9324 | $5.6282 | $5.8474 | +475.96% |
| August, 2030 | $6.2631 | $6.2631 | $6.0453 | +508.07% |
| September, 2030 | $6.0787 | $6.2923 | $6.1195 | +490.17% |
| October, 2030 | $4.5708 | $4.8708 | $5.2702 | +343.77% |
| November, 2030 | $5.2515 | $4.5136 | $3.36 | +409.85% |
| December, 2030 | $2.842 | $3.3871 | $4.9929 | +175.92% |
1.02%
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):